LGALS9 and non-small cell lung carcinoma: It was reported that Gal-9 delta 5, instead of other Gal-9 variants, was the prognostic marker for NSCLC.59 The interaction between various immune biomarkers and immune cells might explain the inconsistent findings of outcome prediction ability of immune biomarkers in different researches.